Virginia Senate Bill SB1048

Virginia 2023 Regular Session

• Introduced: 1/8/23
• Refer: 1/8/23
• Report Pass: 1/31/23
• Engrossed: 2/2/23
• Refer: 2/10/23

Caption

Research and development expenses; tax credits.

Impact

The bill outlines specific percentages for tax credits based on various thresholds and conditions related to the research and development expenses incurred. For instance, businesses investing a certain amount would qualify for incremental tax credits, reinforcing the fiscal benefits for those engaging in applicable research that aligns with state priorities. An increase in tax credit caps, particularly for expenses that exceed $5 million, reflects a concerted effort to incentivize larger enterprises to conduct research in Virginia.

Summary

SB1048 proposes amendments to the Code of Virginia concerning tax credits for research and development expenses. This bill seeks to encourage businesses engaged in qualifying research activities within the state by offering them a tax credit aimed at offsetting some of their expenses. By doing so, SB1048 aims to foster a conducive environment for innovation and attract more companies to invest in research, which can ultimately contribute to the state’s economic growth.

Contention

Notably, the bill includes restrictions that prevent the granting of tax credits for research involving human cells or tissue derived from induced abortions or stem cells obtained from human embryos, which can be a point of contention among legislators and various interest groups. Some may argue that such restrictions limit scientific exploration, while proponents believe it aligns with ethical considerations and reflects public sentiment. The discussions around the bill may often reflect broader societal debates on the balance between innovation and ethical research practices.